Stockholm-based preventative healthcare technology company, Neko Health, raises €250 million in Series B funding.Funding round led by Lightspeed Venture Partners, with participation from other investors.Neko Health aims to expand globally, including the US, and invest in R&D.The company offers non-invasive body scans for preventive care and early detection.